Actor Portrayal


Actor Portrayal
MORE THAN 30 MILLION PATIENT YEARS OF EXPOSURE WITH OVER 685 MILLION UNITS.2*
Venofer® (iron sucrose) injection, USP is an established and effective treatment for chronic kidney disease (CKD) patients experiencing iron deficiency anemia (IDA).
About VenoferVenofer provides IV iron therapy for the treatment of IDA in adult and pediatric patients 2 years and older with CKD. The dosing for iron replacement treatment in pediatric patients with peritoneal dialysis-dependent CKD, hemodialysis-dependent CKD, or non-dialysis-dependent CKD has not been established.
*Patient years are calculated based on an estimated annual cumulative dose of 2,000 mg administered. 2 A unit is a 100 mg iron equivalent sold.
Find Venofer dosing and administration instructions for adult and pediatric patients with CKD.

Vials not actual size
AR Assist Patient Assistance Program
American Regent® created the AR Assist Patient Assistance Program to provide Venofer free of charge to eligible patients who lack insurance coverage or who are underinsured with demonstrated financial need.
Providers (hospitals, physicians, or infusion centers) may apply to the program on behalf of their patients.
DETAILS & FORMSAmerican Regent, Inc. reserves the right to modify or cancel the program immediately with respect to any patient, or in its entirely, at any time. Additional terms and conditions apply.
CODING & REIMBURSEMENT SUPPORT
Find Venofer coding and reimbursement information.
CODING & REIMBURSEMENTReimbursement Assistance
AR Assist is a resource designed to help physicians and other providers understand payers’ coverage and reimbursement policies for Venofer.
Monday through Friday, from 8 AM to 7 PM ET
REFERENCES
1. IQVIA. NSP Audit [January 2020 to January 2025].
2. Data on file. Iron Sucrose Periodic Safety Update Report, 2023. American Regent, Inc.